drugset
drugset / Trial / NCT07564063

Enhanced Recovery After Surgery in Hysterectomy Patients

NCT07564063 ↗

Not yet recruiting 78 enrolled Cairo University
RandomizedParallel-groupSingle-blindSupportive care

Summary

This prospective randomized controlled clinical trial aims to evaluate the effectiveness of Enhanced Recovery After Surgery (ERAS) protocols in patients undergoing elective hysterectomy. ERAS is an evidence-based perioperative approach designed to reduce surgical stress, accelerate recovery, and improve clinical outcomes. Participants will be randomized to receive either ERAS-based care or conventional perioperative management. The study will assess whether ERAS implementation reduces hospital stay and improves postoperative recovery without increasing complications.

Timeline

Start
2026-06-01
Primary completion
2026-12-01
Completion
2027-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dextrose Unknown 5 % Intravenous
Comparator Dextrose Unknown 500 ml Intravenous

Indications

No indication recorded.